021-51111890
购物车（）
sales@molnova.cn
NSC 95397
CAS No. 93718-83-3
NSC 95397 ( —— )
产品货号. M21001 CAS No. 93718-83-3
NSC 95397 is a ?potent inhibitor of Cdc25 dual specificity phosphatase(Ki of 32 96 and 40 nM for Cdc25A Cdc25B and Cdc25C respectively).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥518 | 有现货 |
|
| 10MG | ￥753 | 有现货 |
|
| 25MG | ￥1596 | 有现货 |
|
| 50MG | ￥2657 | 有现货 |
|
| 100MG | ￥4560 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NSC 95397
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述NSC 95397 is a ?potent inhibitor of Cdc25 dual specificity phosphatase(Ki of 32 96 and 40 nM for Cdc25A Cdc25B and Cdc25C respectively).
-
产品描述NSC 95397 is a ?potent inhibitor of Cdc25 dual specificity phosphatase(Ki of 32 96 and 40 nM for Cdc25A Cdc25B and Cdc25C respectively).
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Phosphatase
-
受体Phosphatase
-
研究领域——
-
适应症——
化学信息
-
CAS Number93718-83-3
-
分子量310.39
-
分子式C14H14O4S2
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL (322.18 mM)
-
SMILESO=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21
-
化学全称23-Bis(2-hydroxyethylsulfanyl)naphthalene-14-dione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Navneet D Bou-Yue P Chien-Min L et al. NSC 95397 Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK1/2 Pathway[J]. International Journal of Molecular Sciences 2018 19(6):1625-.
产品手册
关联产品
-
Aloe-emodin-8-O-beta...
Aloe-emodin-8-O-beta-D-glucopyranoside shows moderate bioactivity against human Protein Tyrosine Phosphatase 1B (hPTP1B) in vitro.
-
SHP099
SHP099 free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
-
SC-43
SC-43 is a potent and orally active agonist of SHP-1 (PTPN6). SC-43 inhibits the phosphorylation of STAT3 and induces cell apoptosis, and with anti-fibrotic and anticancer effects.SC-43, a sorafenib derivative.
